日前,宾夕法尼亚制药商Zynerba Pharmaceuticals把目光投向了华尔街,欲进行4200万美元的IPO,推动印度大麻类疗法治疗中枢神经系统(CNS)疾病。
该公司为每股定价14美元,共300万股,并为其承销商预留45万股,总价高达5180万美元。
Zynerba将运用募得资金大力推进两项早期...查看全文
割资本主义羊毛2016-03-15 05:28
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ low float 生技股即便和自己无关,沾$GW PHARMACEUTICALS PLC(GWPH)$ 成功的光,也能翻个几倍,像$CELATOR PHARMACEUTICALS INC(CPXX)$ 成功的 low float 生技股就更疯了。所以,生技股里的小盘low float 既是优先赌票,又是禁触赌票,区别在于头寸赌资是不...查看全文
胖猴围脖2016-03-15 03:54
回复@德米安: 只要试验失败就完蛋,但如果关键试验数据不错,或者通过FDA批准一下子就涨超过50%$Zynerba Pharmaceuticals, Inc.(ZYNE)$ $GW PHARMACEUTICALS PLC(GWPH)$//@德米安:回复@metal:医疗行业水太深了,12年的时候亲眼见证好几家研究癌症药物的公司股价一天跌90%以上,场面非常震撼查看全文
割资本主义羊毛2015-08-11 02:15
尤其是在ibb触EMA60强势反弹的今天,美股有两只股的走势完全就是insane,$Aquinox Pharmaceuticals, Inc.(AQXP)$ 是实验失败暴跌后又误打误撞弄出了个镇痛药,$Zynerba Pharmaceuticals, Inc.(ZYNE)$ 大麻素狗皮膏镇痛药本来只是在ipo第一天因为大麻加镇痛药疯了一下,第二天6位又是前默克又是前FD...查看全文
$Zynerba制药(ZYNE)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001140361-23-048880 Act: 34 Size: 10 KB 网页链接
$Zynerba制药(ZYNE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002969 Act: 33 Size: 1 KB 网页链接
$Zynerba制药(ZYNE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-23-047746 Size: 13 KB 网页链接
$Zynerba制药(ZYNE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-23-047733 Size: 13 KB 网页链接
$Zynerba制药(ZYNE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-23-047742 Size: 13 KB 网页链接
$Zynerba制药(ZYNE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-23-047743 Size: 13 KB 网页链接
$Zynerba制药(ZYNE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-23-047738 Size: 13 KB 网页链接
$Zynerba制药(ZYNE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-23-047735 Size: 13 KB 网页链接
$Zynerba制药(ZYNE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-23-047727 Size: 13 KB 网页链接
$Zynerba制药(ZYNE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-23-047725 Size: 13 KB 网页链接